NTLA / Intellia Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

Azioni in circolazione 107,346,886 shares
Azioni degli insider28.727.018 shares
Proprietà degli insider26,76 %
Numero totale di insider51
Indice del sentiment degli insider

L'indice del sentiment degli insider identifica le società le cui azioni vengono acquistate dagli insider aziendali.

È il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di insider. Il modello di punteggio utilizza una combinazione del numero netto di acquisti degli insider negli ultimi 90 giorni, delle azioni totali acquistate in percentuale del flottante e delle azioni totali possedute dagli insider. Il punteggio varia da 0 a 100: i numeri più alti indicano un livello di accumulo superiore ad altre società, mentre 50 rappresenta la media.

Frequenza di aggiornamento: giornaliera

Vedi I preferiti degli insider, per accedere all'elenco delle società con il più alto accumulo di insider.

Indice del sentiment dei dirigenti

L'indice del sentiment dei dirigenti identifica le società le cui azioni vengono acquistate dai dirigenti aziendali.

Per definizione, i dirigenti aziendali sono insider della società, ma a differenza di altri insider (azionisti al 10% e membri del consiglio di amministrazione), i dirigenti lavorano quotidianamente per la società e utilizzano il proprio denaro quando fanno trading (gli azionisti al 10% e i membri del consiglio di amministrazione sono spesso gestori di fondi che gestiscono il denaro di altre persone). Pertanto, le operazioni di insider trading effettuate dai dirigenti sono molto più significative e devono essere trattate in modo appropriato.

Come l'indice del sentiment degli insider, l'indice del sentiment dei dirigenti è il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di dirigenti.

Frequenza di aggiornamento: giornaliera

Vedi I preferiti degli insider, per accedere all'elenco delle società con il più alto sentiment degli insider.

Principali indicatori per gli insider

Questa scheda mostra il posizionamento della società in base a diversi indicatori di insider. Il grado percentile mostra come la società si colloca rispetto alle altre società dei mercati statunitensi. Posizioni più alte indicano situazioni migliori.

Ad esempio, è generalmente accettato che gli acquisti di insider siano un indicatore positivo, per cui le società con un maggior numero di acquisti di insider si classificherebbero più in alto rispetto a quelle con un minor numero di acquisti di insider (o addirittura di vendite di insider).

Numero netto di acquisti di insider (classifica)

-3 ( )

10663 out of 11323

Il numero netto di acquisti di insider è il numero totale di acquisti di insider meno il numero totale di vendite di insider negli ultimi 90 giorni. Il grado percentile è mostrato qui (intervallo da 0 a 100%).

Percentuale del flottante acquistato dagli insider (classifica)

0.084 %( )

275 out of 11244

La percentuale del flottante acquistato dagli insider è data dal numero totale di azioni acquistate dagli insider meno il numero totale di azioni vendute dagli insider negli ultimi 90 giorni, divisa per il flottante totale e moltiplicata per 100.

Grafico sull'insider trading

Il grafico seguente mostra le operazioni di insider trading di Intellia Therapeutics, Inc.. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4.

Lista degli insider e indicatori di redditività

Questa tabella mostra la lista degli insider noti ed è generata automaticamente a partire dai depositi effettuati presso la SEC. Oltre ai nomi, al titolo più recente e alla designazione di amministratore, funzionario o proprietario al 10%, forniamo le ultime partecipazioni divulgate. Inoltre, quando possibile, forniamo la performance storica delle transazioni dell'insider. La performance storica delle transazioni è una media ponderata della performance delle operazioni di acquisto sul mercato aperto effettuate dall'insider. Per maggiori informazioni su come viene calcolata, guarda questo webinar su YouTube.

See our leaderboard of most profitable insider traders.

Insider Utile medio (%) Azioni
possedute
Rettificato
per il frazionamento azionario
Atlas Venture Associates IX, L.P. 10% Owner - [10%] 3.579.788 3.579.788
Atlas Venture Associates IX, LLC 10% Owner - [10%] 3.579.788 3.579.788
Atlas Venture Fund IX, L.P. 10% Owner - [10%] 3.579.788 3.579.788
Baker Bros. Advisors Lp - 976.214 976.214
Felix Baker 10% Owner - [10%] 976.214 976.214
Julian Baker 10% Owner - [10%] 976.214 976.214
James Basta EVP, General Counsel - [O] 111.925 111.925
Baker Bros. Advisors (GP) LLC 10% Owner - [10%] 976.214 976.214
Barnes Thomas M. Chief Scientific Officer - [O] 349.614 349.614
Graeme Bell EVP, Chief Financial Officer - [O] 21.400 21.400
Nessan Bermingham President & CEO, Director - [D] [O] 458.250 458.250
Muna Bhanji Director - [D] 27.203 27.203
William J Chase Director - [D] 134.693 134.693
Caribou Biosciences, Inc. 10% Owner - [10%] 3.994.355 3.994.355
Caribou Therapeutics Holdco, LLC 10% Owner - [10%] 5.593.846 5.593.846
Eliana Clark EVP, Chief Technical Officer - [O] 95.369 95.369
Fred E Cohen Director - [D] 57.453 57.453
Insider Utile medio (%) Azioni
possedute
Rettificato
per il frazionamento azionario
John F Crowley Director - [D] 11.716 11.716
Caroline Dorsa Director - [D] 12.701 12.701
Michael P Dube VP, Chief Accounting Officer - [O] 57.137 57.137
Edward J III Dulac EVP, Chief Financial Officer - [O] 106.062 106.062
Jean Francois Formela Director - [D] 7.291 7.291
Management Pte Ltd Fullerton 10% Owner - [10%] 790.527 790.527
Jesse Goodman Director - [D] 24.359 24.359
Carl L Gordon Director - [D] 2.662.180 2.662.180
Glenn Goddard EVP, Chief Financial Officer - [O] 69.213 69.213
Brian Goff Director - [D] 23.409 23.409
Haurwitz Rachel E. Director, 10% Owner - [D] [10%] 5.593.846 5.593.846
Nicole Heifner Principal Accounting Officer - [O] 129.410 129.410
Derek Hicks EVP, Chief Business Officer - [O] 59.878 59.878
Samuel D Isaly 10% Owner - [10%] 2.662.180 2.662.180
Perry A Karsen Director - [D] 5.000 5.000
Georgia Keresty Director - [D] 31.883 31.883
Leonard John M. President and CEO, Director - [D] [O] 1.135.530 1.135.530
Insider Utile medio (%) Azioni
possedute
Rettificato
per il frazionamento azionario
David Lebwohl EVP, Chief Medical Officer - [O] 130.866 130.866
David V Morrissey Chief Technology Officer - [O] 349.614 349.614
Ag Novartis 10% Owner - [10%] 4.352.295 4.352.295
Novartis Institutes for BioMedical Research, Inc. 10% Owner - [10%] 4.352.295 4.352.295
Orbimed Advisors Llc Director - [D] 2.662.180 2.662.180
OrbiMed Capital GP V LLC 10% Owner - [10%] 2.662.180 2.662.180
OrbiMed Global Healthcare GP LLC 10% Owner - [10%] 2.662.180 2.662.180
Jose E Rivera EVP, General Counsel - [O] 162.388 162.388
Andrew Schiermeier EVP, Chief Operating Officer - [O] 16.656 16.656
Birgit C Schultes EVP, Chief Scientific Officer - [O] 105.215 105.215
Laura Sepp-Lorenzino EVP, Chief Scientific Officer - [O] 77.388 77.388
Moncef Slaoui 38.000
Sapna Srivastava Chief Financial & Stategy Offr - [O] 318.062 318.062
TLS Beta Pte. Ltd. 10% Owner - [10%] 790.527 790.527
Temasek Holdings (Private) Ltd 10% Owner - [10%] 790.527 790.527
Temasek Life Sciences Private Ltd 10% Owner - [10%] 790.527 790.527
Frank Verwiel Director - [D] 25.948 25.948

Report errors via our new Insider Auditing Tool

Storico degli acquisti di insider - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider effettuato sul mercato aperto in NTLA / Intellia Therapeutics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2025-08-20 CHASE WILLIAM J 100.000 10,0300 100.000 10,0300 1.003.000 16 12.0600 203.000 20,24
2019-03-06 SCHIERMEIER ANDREW 3.250 16,0000 3.250 16,0000 52.000
2019-03-06 SCHIERMEIER ANDREW 4.250 15,5000 4.250 15,5000 65.875
2016-05-11 Novartis Institutes for BioMedical Research, Inc. 277.777 18,0000 277.777 18,0000 4.999.986
2016-05-11 BAKER BROS. ADVISORS LP 179.531 18,0000 179.531 18,0000 3.231.558
2016-05-11 BAKER BROS. ADVISORS LP 20.469 18,0000 20.469 18,0000 368.442
2016-05-11 ORBIMED ADVISORS LLC 58.534 18,0000 58.534 18,0000 1.053.612
2016-05-11 ORBIMED ADVISORS LLC 191.466 18,0000 191.466 18,0000 3.446.388
2016-05-11 Temasek Holdings (Private) Ltd 300.000 18,0000 300.000 18,0000 5.400.000

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.

NTLA / Intellia Therapeutics, Inc. Insider Trades
Storico delle vendite di insider - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in NTLA / Intellia Therapeutics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
2025-07-23 Dulac Edward J III 7.462 14,0200 7.462 14,0200 104.617 29 10.1250 -29.064 -27,78
2025-07-02 Dube Michael P 2.503 9,9500 2.503 9,9500 24.905
2025-07-01 Clark Eliana 1.022 9,8200 1.022 9,8200 10.036
2025-03-04 Clark Eliana 679 8,9900 679 8,9900 6.104
2025-03-04 BASTA JAMES 2.572 8,9900 2.572 8,9900 23.122
2025-01-03 Clark Eliana 7.422 12,1800 7.422 12,1800 90.400
2025-01-03 Sepp-Lorenzino Laura 8.966 12,1800 8.966 12,1800 109.206
2025-01-03 Hicks Derek 6.502 12,1800 6.502 12,1800 79.194
2025-01-03 Dube Michael P 1.372 12,1800 1.372 12,1800 16.711

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.

NTLA / Intellia Therapeutics, Inc. Insider Trades
Storico delle transazioni

Clicca sull'icona del link per visualizzare la cronologia completa delle transazioni. Le transazioni segnalate come parte di un piano di trading automatico 10b5-1 saranno contrassegnate con una X nella colonna contrassegnata con 10b-5.

Data di
deposito
Data dell'
operazione
Modulo Insider Ticker Titolo Codice 10b5-1 Diretto Prezzo
di esercizio
Prezzo
unitario
Unità
modificate
Valore
modificato (1K)
Opzioni
rimanenti
Azioni
rimanenti
2025-08-22 2025-08-20 4 CHASE WILLIAM J NTLA Common Stock P - Purchase D 10,0300 100.000 1.003 134.693
2025-07-25 2025-07-23 4 Dulac Edward J III NTLA Common Stock S - Sale D 14,0200 -7.462 -105 106.062
2025-07-03 2025-07-01 4 Clark Eliana NTLA Common Stock S - Sale D 9,8200 -1.022 -10 95.369
2025-07-03 2025-07-02 4 Dube Michael P NTLA Common Stock S - Sale D 9,9500 -2.503 -25 57.137
2025-07-02 2025-07-01 4 GOODMAN JESSE NTLA Common Stock S - Sale D 9,2300 -1.547 -14 24.359
2025-07-02 2025-06-30 4 GOODMAN JESSE NTLA Common Stock S - Sale D 9,5600 -1.547 -15 25.906
2025-06-18 2025-06-11 4 Keresty Georgia NTLA Common Stock A - Award D 8.000 31.883
2025-06-13 2025-06-11 4 Verwiel Frank NTLA Common Stock A - Award D 8.000 25.948
2025-06-13 2025-06-11 4 GOODMAN JESSE NTLA Common Stock A - Award D 8.000 27.453
2025-06-13 2025-06-11 4 Goff Brian NTLA Common Stock A - Award D 8.000 23.409
2025-06-13 2025-06-11 4 Bhanji Muna NTLA Common Stock A - Award D 8.000 27.203
2025-06-13 2025-06-11 4 CHASE WILLIAM J NTLA Common Stock A - Award D 8.000 34.693
2025-06-13 2025-06-11 4 Cohen Fred E NTLA Common Stock A - Award D 8.000 57.453
2025-05-01 2025-04-29 4 Bhanji Muna NTLA Common Stock S - Sale D 8,5000 -265 -2 19.203
2025-03-04 2025-03-04 4 Clark Eliana NTLA Common Stock S - Sale D 8,9900 -679 -6 95.369
2025-03-04 2025-03-01 4 Clark Eliana NTLA Common Stock A - Award D 32.000 96.048
2025-03-04 2025-03-01 4 LEONARD JOHN M. NTLA Common Stock A - Award D 136.000 1.077.115
2025-03-04 2025-03-01 4 Dulac Edward J III NTLA Common Stock A - Award D 47.200 113.524
2025-03-04 2025-03-01 4 Dube Michael P NTLA Common Stock A - Award D 14.000 59.640
2025-03-04 2025-03-01 4 Lebwohl David NTLA Common Stock A - Award D 43.200 130.866
2025-03-04 2025-03-01 4 Schultes Birgit C NTLA Common Stock A - Award D 37.600 105.215
2025-03-04 2025-03-04 4 BASTA JAMES NTLA Common Stock S - Sale D 8,9900 -2.572 -23 111.925
2025-03-04 2025-03-01 4 BASTA JAMES NTLA Common Stock A - Award D 40.000 114.497
2025-01-31 2025-01-29 4 Bhanji Muna NTLA Common Stock S - Sale D 9,9700 -265 -3 19.468
2025-01-23 3 Schultes Birgit C NTLA Common Stock D 67.615
2025-01-07 2025-01-03 4 Dube Michael P NTLA Common Stock S - Sale D 12,1800 -1.372 -17 45.640
2025-01-07 2025-01-03 4 BASTA JAMES NTLA Common Stock S - Sale D 12,1800 -7.074 -86 74.497
2025-01-07 2025-01-03 4 Hicks Derek NTLA Common Stock S - Sale D 12,1800 -6.502 -79 59.878
2025-01-07 2025-01-03 4 Lebwohl David NTLA Common Stock S - Sale D 12,1800 -9.557 -116 87.666
2025-01-07 2025-01-03 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 12,1800 -26.807 -327 941.115
2025-01-07 2025-01-03 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 12,1800 -8.966 -109 77.388
2025-01-06 2025-01-03 4 Clark Eliana NTLA Common Stock S - Sale D 12,1800 -7.422 -90 64.048
2025-01-06 2025-01-02 4 Clark Eliana NTLA Common Stock S - Sale D 12,0300 -556 -7 71.470
2025-01-03 2025-01-01 4 Lebwohl David NTLA Common Stock M - Exercise D 3.189 97.223
2025-01-03 2025-01-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 7.850 967.922
2025-01-03 2025-01-01 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 3.500 86.354
2024-10-04 2024-10-02 4 Dube Michael P NTLA Common Stock S - Sale D 19,0100 -2.012 -38 47.012
2024-07-24 2024-07-22 4 Dulac Edward J III NTLA Common Stock A - Award D 66.324 66.324
2024-07-03 2024-07-01 4 Dube Michael P NTLA Common Stock A - Award D 17.801 49.024
2024-07-03 2024-07-01 4 Clark Eliana NTLA Common Stock S - Sale D 22,9300 -405 -9 71.470
2024-06-20 2024-06-17 4 Verwiel Frank NTLA Common Stock S - Sale D 25,0000 -1.505 -38 17.948
2024-06-17 2024-06-13 4 Goff Brian NTLA Common Stock A - Award D 15.409 15.409
2024-06-14 2024-06-12 4 Verwiel Frank NTLA Common Stock A - Award D 7.737 19.453
2024-06-14 2024-06-12 4 GOODMAN JESSE NTLA Common Stock A - Award D 7.737 19.453
2024-06-14 2024-06-12 4 Keresty Georgia NTLA Common Stock A - Award D 7.737 23.883
2024-06-14 2024-06-12 4 Cohen Fred E NTLA Common Stock A - Award D 7.737 49.453
2024-06-14 2024-06-12 4 Bhanji Muna NTLA Common Stock A - Award D 7.737 19.733
2024-06-14 2024-06-12 4 CHASE WILLIAM J NTLA Common Stock A - Award D 7.737 26.693
2024-04-22 3 Dube Michael P NTLA Common Stock D 31.223
2024-03-05 2024-03-01 4 Goddard Glenn NTLA Common Stock A - Award D 28.628 69.213
2024-03-05 2024-03-01 4 Lebwohl David NTLA Common Stock A - Award D 38.701 93.073
2024-03-05 2024-03-01 4 LEONARD JOHN M. NTLA Common Stock A - Award D 113.586 960.072
2024-03-05 2024-03-04 4 Clark Eliana NTLA Common Stock S - Sale D 32,9900 -605 -20 71.470
2024-03-05 2024-03-01 4 Clark Eliana NTLA Common Stock A - Award D 31.230 72.075
2024-03-05 2024-03-04 4 BASTA JAMES NTLA Common Stock S - Sale D 32,9900 -2.297 -76 81.571
2024-03-05 2024-03-01 4 BASTA JAMES NTLA Common Stock A - Award D 32.394 83.868
2024-03-05 2024-03-01 4 Hicks Derek NTLA Common Stock A - Award D 29.393 66.380
2024-03-05 2024-03-01 4 Sepp-Lorenzino Laura NTLA Common Stock A - Award D 37.966 81.893
2024-01-10 2024-01-08 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 29,3800 -667 -20 43.927
2024-01-10 2024-01-08 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 28,6600 -1.608 -46 44.594
2024-01-05 2024-01-03 4 Lebwohl David NTLA Common Stock S - Sale D 29,4600 -5.843 -172 54.372
2024-01-05 2024-01-03 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 29,4600 -19.223 -566 846.486
2024-01-05 2024-01-03 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 29,4600 -5.532 -163 46.202
2024-01-05 2024-01-03 4 Goddard Glenn NTLA Common Stock S - Sale D 29,4600 -5.365 -158 40.585
2024-01-05 2024-01-03 4 Hicks Derek NTLA Common Stock S - Sale D 29,4600 -3.877 -114 36.987
2024-01-05 2024-01-03 4 BASTA JAMES NTLA Common Stock S - Sale D 29,4600 -3.805 -112 51.474
2024-01-05 2024-01-03 4 Clark Eliana NTLA Common Stock S - Sale D 29,4600 -4.301 -127 40.845
2024-01-05 2024-01-03 4 Clark Eliana NTLA Common Stock S - Sale D 30,1200 -307 -9 45.146
2024-01-03 2024-01-01 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 3.500 51.734
2024-01-03 2024-01-01 4 Lebwohl David NTLA Common Stock M - Exercise D 3.187 60.215
2024-01-03 2024-01-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 7.848 865.709
2024-01-03 2024-01-01 4 Goddard Glenn NTLA Common Stock M - Exercise D 3.062 45.950
2023-11-02 2023-10-31 4 Bhanji Muna NTLA Common Stock S - Sale D 23,9000 -265 -6 11.996
2023-08-02 2023-07-31 4 Bhanji Muna NTLA Common Stock S - Sale D 42,3300 -265 -11 12.261
2023-07-10 2023-07-06 4 Bhanji Muna NTLA Common Stock S - Sale D 39,3000 -1.867 -73 12.526
2023-07-06 2023-07-03 4 Clark Eliana NTLA Common Stock S - Sale D 40,5100 -360 -15 45.146
2023-06-22 2023-06-20 4 Clark Eliana NTLA Common Stock S - Sale D 45,0000 -5.000 -225 45.146
2023-06-22 2023-06-20 4 Clark Eliana NTLA Common Stock M - Exercise D 12,2700 5.000 61 50.146
2023-06-16 2023-06-14 4 CHASE WILLIAM J NTLA Common Stock A - Award D 1.673 18.956
2023-06-16 2023-06-14 4 Verwiel Frank NTLA Common Stock A - Award D 4.425 11.716
2023-06-16 2023-06-14 4 GOODMAN JESSE NTLA Common Stock A - Award D 4.425 11.716
2023-06-16 2023-06-14 4 Keresty Georgia NTLA Common Stock A - Award D 4.425 16.146
2023-06-16 2023-06-14 4 Cohen Fred E NTLA Common Stock A - Award D 4.425 41.716
2023-06-16 2023-06-14 4 Crowley John F NTLA Common Stock A - Award D 4.425 11.716
2023-06-16 2023-06-14 4 Bhanji Muna NTLA Common Stock A - Award D 4.425 14.393
2023-04-18 2023-04-14 4 CHASE WILLIAM J NTLA Common Stock A - Award D 10.483 17.283
2023-04-18 3 CHASE WILLIAM J NTLA Common Stock D 6.800
2023-03-03 2023-03-01 4 Hicks Derek NTLA Common Stock A - Award D 23.558 40.864
2023-03-03 2023-03-01 4 Goddard Glenn NTLA Common Stock A - Award D 27.484 42.888
2023-03-03 2023-03-01 4 LEONARD JOHN M. NTLA Common Stock A - Award D 91.036 857.861
2023-03-03 2023-03-01 4 Lebwohl David NTLA Common Stock A - Award D 30.674 56.361
2023-03-03 2023-03-01 4 Sepp-Lorenzino Laura NTLA Common Stock A - Award D 29.938 47.567
2023-03-03 2023-03-01 4 Clark Eliana NTLA Common Stock A - Award D 6.134 45.146
2023-03-03 2023-03-01 4 Clark Eliana NTLA Common Stock A - Award D 24.539 39.012
2023-03-03 2023-03-02 4 BASTA JAMES NTLA Common Stock S - Sale D 43,8800 -1.088 -48 55.279
2023-03-03 2023-03-01 4 BASTA JAMES NTLA Common Stock A - Award D 12.269 56.367
2023-03-03 2023-03-01 4 BASTA JAMES NTLA Common Stock A - Award D 24.539 44.098
2023-01-06 2023-01-04 4 Goddard Glenn NTLA Common Stock S - Sale D 37,2100 -2.427 -90 15.404
2023-01-06 2023-01-04 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 37,2100 -6.673 -248 766.825
2023-01-06 2023-01-05 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 39,1000 -689 -27 17.629
2023-01-06 2023-01-05 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 38,2200 -1.641 -63 18.318
2023-01-06 2023-01-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 37,2100 -2.508 -93 19.959
2023-01-06 2023-01-04 4 BASTA JAMES NTLA Common Stock S - Sale D 37,2100 -1.138 -42 19.559
2023-01-06 2023-01-04 4 Lebwohl David NTLA Common Stock S - Sale D 37,2100 -2.574 -96 25.687
2023-01-06 2023-01-04 4 Clark Eliana NTLA Common Stock S - Sale D 37,2100 -1.692 -63 14.473
2023-01-06 2023-01-03 4 Clark Eliana NTLA Common Stock S - Sale D 34,4800 -231 -8 16.165
2023-01-06 2022-07-01 4 Clark Eliana NTLA Common Stock S - Sale D 51,7400 -105 -5 16.165
2023-01-06 2023-01-04 4 Hicks Derek NTLA Common Stock S - Sale D 37,2100 -1.812 -67 17.306
2023-01-04 2023-01-01 4 Goddard Glenn NTLA Common Stock M - Exercise D 3.062 17.831
2023-01-04 2023-01-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 7.848 773.498
2023-01-04 2023-01-01 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 3.500 22.467
2023-01-04 2023-01-01 4 Lebwohl David NTLA Common Stock M - Exercise D 3.187 28.261
2022-06-16 2022-06-14 4 Verwiel Frank NTLA Common Stock A - Award D 5.197 7.291
2022-06-16 2022-06-14 4 Keresty Georgia NTLA Common Stock A - Award D 5.197 11.721
2022-06-16 2022-06-14 4 GOODMAN JESSE NTLA Common Stock A - Award D 5.197 7.291
2022-06-16 2022-06-14 4 FORMELA JEAN FRANCOIS NTLA Common Stock A - Award D 5.197 7.291
2022-06-16 2022-06-14 4 DORSA CAROLINE NTLA Common Stock A - Award D 5.197 12.701
2022-06-16 2022-06-14 4 Crowley John F NTLA Common Stock A - Award D 5.197 7.291
2022-06-16 2022-06-14 4 Cohen Fred E NTLA Common Stock A - Award D 5.197 37.291
2022-06-16 2022-06-14 4 Bhanji Muna NTLA Common Stock A - Award D 2.014 9.968
2022-05-02 2022-04-28 4 Bhanji Muna NTLA Stock Option (Right to Buy) A - Award D 50,29 11.700 11.700
2022-05-02 2022-04-28 4 Bhanji Muna NTLA Common Stock A - Award D 7.954 7.954
2022-04-14 2021-06-23 4/A Keresty Georgia NTLA Stock Option (right to buy) A - Award D 83,59 2.534 2.534
2022-04-14 2021-06-23 4/A Keresty Georgia NTLA Common Stock A - Award D 1.569 6.524
2022-03-07 2022-03-01 4 Clark Eliana NTLA Stock Option (right to buy) A - Award D 79,85 15.395 15.395
2022-03-07 2022-03-01 4 Clark Eliana NTLA Common Stock A - Award D 10.527 16.165
2022-03-07 3 Clark Eliana NTLA Common Stock D 5.638
2022-03-04 2022-03-01 4/A BASTA JAMES NTLA Stock Option (right to buy) A - Award D 79,85 14.109 14.109
2022-03-04 2022-03-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 79,85 59.941 59.941
2022-03-04 2022-03-01 4 LEONARD JOHN M. NTLA Common Stock A - Award D 40.990 765.650
2022-03-04 2022-01-01 4 LEONARD JOHN M. NTLA Restricted Stock Unit M - Exercise D -7.848 23.546
2022-03-04 2022-01-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 112,2550 -2.493 -280 724.660
2022-03-04 2022-01-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 7.848 727.153
2022-03-04 2022-03-01 4/A Goddard Glenn NTLA Stock Option (right to buy) A - Award D 79,85 18.600 18.600
2022-03-04 2022-03-01 4/A Lebwohl David NTLA Stock Option (right to buy) A - Award D 79,85 20.203 20.203
2022-03-04 2022-03-01 4/A Sepp-Lorenzino Laura NTLA Stock Option (right to buy) A - Award D 79,85 20.203 20.203
2022-03-03 2022-03-01 4 Sepp-Lorenzino Laura NTLA Stock Option (right to buy) A - Award D 79,85 13.816 13.816
2022-03-03 2022-03-01 4 Sepp-Lorenzino Laura NTLA Common Stock A - Award D 13.816 18.631
2022-03-03 2022-01-01 4 Sepp-Lorenzino Laura NTLA Restricted Stock Unit M - Exercise D -3.500 10.500
2022-03-03 2022-01-01 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 112,2500 -1.148 -129 4.815
2022-03-03 2022-01-01 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 3.500 5.963
2022-03-03 2022-03-01 4 Lebwohl David NTLA Stock Option (right to buy) A - Award D 79,85 13.816 13.816
2022-03-03 2022-03-01 4 Lebwohl David NTLA Common Stock A - Award D 13.816 24.738
2022-03-03 2022-01-01 4 Lebwohl David NTLA Restricted Stock Unit M - Exercise D -3.187 9.563
2022-03-03 2022-01-01 4 Lebwohl David NTLA Common Stock S - Sale D 112,2400 -1.051 -118 10.922
2022-03-03 2022-01-01 4 Lebwohl David NTLA Common Stock M - Exercise D 3.187 11.973
2022-03-03 2022-03-01 4 Goddard Glenn NTLA Stock Option (right to buy) A - Award D 79,85 12.720 12.720
2022-03-03 2022-03-01 4 Goddard Glenn NTLA Common Stock A - Award D 12.720 14.769
2022-03-03 2022-01-01 4 Goddard Glenn NTLA Restricted Stock Unit M - Exercise D -3.062 9.188
2022-03-03 2022-01-01 4 Goddard Glenn NTLA Common Stock S - Sale D 112,2400 -1.013 -114 2.049
2022-03-03 2022-01-01 4 Goddard Glenn NTLA Common Stock M - Exercise D 3.062 3.062
2022-03-03 2022-03-01 4 BASTA JAMES NTLA Stock Option (right to buy) A - Award D 79,85 9.648 9.648
2022-03-03 2022-03-01 4 BASTA JAMES NTLA Common Stock A - Award D 9.648 20.697
2022-03-03 2022-03-01 4 BASTA JAMES NTLA Common Stock A - Award D 11.049 11.049
2022-01-05 2022-01-03 4 Hicks Derek NTLA Stock option (right to buy) A - Award D 118,99 25.000 25.000
2022-01-05 2022-01-03 4 Hicks Derek NTLA Common Stock A - Award D 19.118 19.118
2021-11-09 2021-11-05 4 Lebwohl David NTLA Stock Option (right to buy) M - Exercise D 12,62 -2.400 180.077
2021-11-09 2021-11-05 4 Lebwohl David NTLA Common Stock S - Sale D 135,3400 -200 -27 8.714
2021-11-09 2021-11-05 4 Lebwohl David NTLA Common Stock S - Sale D 134,0700 -548 -73 8.914
2021-11-09 2021-11-05 4 Lebwohl David NTLA Common Stock S - Sale D 132,6200 -452 -60 9.462
2021-11-09 2021-11-05 4 Lebwohl David NTLA Common Stock S - Sale D 131,7100 -1.200 -158 9.914
2021-11-09 2021-11-05 4 Lebwohl David NTLA Common Stock M - Exercise D 12,6200 2.400 30 11.114
2021-10-15 2021-10-14 4 Lebwohl David NTLA Stock Option (right to buy) M - Exercise D 12,62 -2.400 182.477
2021-10-15 2021-10-14 4 Lebwohl David NTLA Common Stock S - Sale D 130,4700 -250 -33 8.714
2021-10-15 2021-10-14 4 Lebwohl David NTLA Common Stock S - Sale D 129,8300 -525 -68 8.964
2021-10-15 2021-10-14 4 Lebwohl David NTLA Common Stock S - Sale D 129,0100 -225 -29 9.489
2021-10-15 2021-10-14 4 Lebwohl David NTLA Common Stock S - Sale D 127,8100 -849 -109 9.714
2021-10-15 2021-10-14 4 Lebwohl David NTLA Common Stock S - Sale D 126,9200 -551 -70 10.563
2021-10-15 2021-10-14 4 Lebwohl David NTLA Common Stock M - Exercise D 12,6200 2.400 30 11.114
2021-10-13 2021-10-11 4 Crowley John F NTLA Stock Option (right to buy) M - Exercise D 18,83 -2.500 25.500
2021-10-13 2021-10-11 4 Crowley John F NTLA Common Stock S - Sale D 119,5500 -2.500 -299 2.094
2021-10-13 2021-10-11 4 Crowley John F NTLA Common Stock M - Exercise D 18,8300 2.500 47 4.594
2021-10-07 2021-10-05 4 Crowley John F NTLA Stock Option (right to buy) M - Exercise D 18,83 -10.000 28.000
2021-10-07 2021-10-05 4 Crowley John F NTLA Common Stock S - Sale D 132,8400 -200 -27 2.094
2021-10-07 2021-10-05 4 Crowley John F NTLA Common Stock S - Sale D 131,7400 -1.846 -243 2.294
2021-10-07 2021-10-05 4 Crowley John F NTLA Common Stock S - Sale D 130,9200 -3.759 -492 4.140
2021-10-07 2021-10-05 4 Crowley John F NTLA Common Stock S - Sale D 129,8800 -2.915 -379 7.899
2021-10-07 2021-10-05 4 Crowley John F NTLA Common Stock S - Sale D 128,8300 -1.280 -165 10.814
2021-10-07 2021-10-05 4 Crowley John F NTLA Common Stock M - Exercise D 18,8300 10.000 188 12.094
2021-09-27 2021-09-24 4 Lebwohl David NTLA Stock Option (right to buy) M - Exercise D 12,62 -7.923 184.877
2021-09-27 2021-09-24 4 Lebwohl David NTLA Common Stock M - Exercise D 12,6200 7.923 100 8.714
2021-09-23 2021-09-21 4 Lebwohl David NTLA Stock Option (right to buy) M - Exercise D 12,62 -2.400 192.800
2021-09-23 2021-09-21 4 Lebwohl David NTLA Common Stock S - Sale D 149,8100 -2.400 -360 791
2021-09-23 2021-09-21 4 Lebwohl David NTLA Common Stock M - Exercise D 12,6200 2.400 30 3.191
2021-09-09 2021-09-07 4 Goddard Glenn NTLA Stock Option (right to buy) M - Exercise D 14,58 -3.482 12.451
2021-09-09 2021-09-07 4 Goddard Glenn NTLA Common Stock S - Sale D 180,1200 -3.482 -627 0
2021-09-09 2021-09-07 4 Goddard Glenn NTLA Common Stock M - Exercise D 14,5800 3.482 51 3.482
2021-09-01 2021-09-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 18,30 -15.985 11.515
2021-09-01 2021-09-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 23,46 -28.750 0
2021-09-01 2021-09-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 170,0000 -44.735 -7.605 719.305
2021-09-01 2021-09-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 18,3000 15.985 293 764.040
2021-09-01 2021-09-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 23,4600 28.750 674 748.055
2021-09-01 2021-08-31 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 14,58 -37.833 90.000
2021-09-01 2021-08-31 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 155,0000 -37.833 -5.864 719.305
2021-09-01 2021-08-31 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 14,5800 37.833 552 757.138
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 14,58 -27.167 127.833
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,40 -11.637 212.501
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 160,6900 -216 -35 719.305
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 159,9800 -725 -116 719.521
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 159,1800 -2.598 -414 720.246
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 157,7500 -3.123 -493 722.844
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 156,9600 -4.758 -747 725.967
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 155,7000 -15.567 -2.424 730.725
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 154,9800 -7.428 -1.151 746.292
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 153,6600 -2.334 -359 753.720
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 152,8100 -2.055 -314 756.054
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 14,5800 27.167 396 758.109
2021-09-01 2021-08-30 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,4000 11.637 156 730.942
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Stock Option (right to buy) M - Exercise D 14,25 -70.000 80.000
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Stock Option (right to buy) M - Exercise D 13,40 -27.000 82.000
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 160,4700 -207 -33 2.391
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 159,6400 -2.653 -424 2.598
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 158,9000 -1.515 -241 5.251
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 157,7700 -3.932 -620 6.766
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 156,7900 -7.425 -1.164 10.698
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 155,6100 -16.115 -2.508 18.123
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 154,7700 -28.669 -4.437 34.238
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 153,6400 -20.645 -3.172 62.907
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 152,7500 -15.839 -2.419 83.552
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 14,2500 70.000 998 99.391
2021-09-01 2021-08-30 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 13,4000 27.000 362 29.391
2021-09-01 2021-08-31 4 Goddard Glenn NTLA Stock Option (right to buy) M - Exercise D 14,58 -1.817 15.933
2021-09-01 2021-08-31 4 Goddard Glenn NTLA Stock Option (right to buy) M - Exercise D 19,27 -22.983 41.817
2021-09-01 2021-08-31 4 Goddard Glenn NTLA Common Stock S - Sale D 160,2200 -24.800 -3.973 0
2021-09-01 2021-08-31 4 Goddard Glenn NTLA Common Stock M - Exercise D 14,5800 1.817 26 24.800
2021-09-01 2021-08-31 4 Goddard Glenn NTLA Common Stock M - Exercise D 19,2700 22.983 443 22.983
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Stock Option (right to buy) M - Exercise D 19,27 -5.200 64.800
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 160,8400 -300 -48 0
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 159,5300 -300 -48 300
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 158,4200 -300 -48 600
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 157,3300 -496 -78 900
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 156,1000 -300 -47 1.396
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 155,2900 -1.700 -264 1.696
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 154,2900 -1.100 -170 3.396
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock S - Sale D 153,2200 -704 -108 4.496
2021-09-01 2021-08-30 4 Goddard Glenn NTLA Common Stock M - Exercise D 19,2700 5.200 100 5.200
2021-09-01 2021-08-30 4 Lebwohl David NTLA Stock Option (right to buy) M - Exercise D 12,62 -2.400 195.200
2021-09-01 2021-08-30 4 Lebwohl David NTLA Common Stock S - Sale D 160,1000 -150 -24 791
2021-09-01 2021-08-30 4 Lebwohl David NTLA Common Stock S - Sale D 159,1900 -1.100 -175 941
2021-09-01 2021-08-30 4 Lebwohl David NTLA Common Stock S - Sale D 157,6000 -250 -39 2.041
2021-09-01 2021-08-30 4 Lebwohl David NTLA Common Stock S - Sale D 156,7000 -700 -110 2.291
2021-09-01 2021-08-30 4 Lebwohl David NTLA Common Stock S - Sale D 155,4300 -200 -31 2.991
2021-09-01 2021-08-30 4 Lebwohl David NTLA Common Stock M - Exercise D 12,6200 2.400 30 3.191
2021-08-25 2021-08-23 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,40 -27.139 224.138
2021-08-25 2021-08-23 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 153,5200 -100 -15 719.305
2021-08-25 2021-08-23 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 153,0800 -8.165 -1.250 719.405
2021-08-25 2021-08-23 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 151,5400 -18.874 -2.860 727.570
2021-08-25 2021-08-23 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,4000 27.139 364 746.444
2021-08-20 2021-08-19 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,40 -22.682 251.277
2021-08-20 2021-08-19 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 152,3000 -5.963 -908 719.305
2021-08-20 2021-08-19 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 151,5600 -6.993 -1.060 725.268
2021-08-20 2021-08-19 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 150,4600 -9.726 -1.463 732.261
2021-08-20 2021-08-19 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,4000 22.682 304 741.987
2021-08-11 2021-08-09 4 Lebwohl David NTLA Stock Option (right to buy) M - Exercise D 12,62 -2.400 197.600
2021-08-11 2021-08-09 4 Lebwohl David NTLA Common Stock S - Sale D 164,0500 -2.400 -394 791
2021-08-11 2021-08-09 4 Lebwohl David NTLA Common Stock M - Exercise D 12,6200 2.400 30 3.191
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Stock Option (right to buy) M - Exercise D 13,40 -26.000 109.000
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 141,6300 -126 -18 2.391
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 140,7300 -4.054 -571 2.517
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 139,8500 -2.772 -388 6.571
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 138,7800 -4.419 -613 9.343
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 137,7200 -6.344 -874 13.762
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 136,7900 -6.814 -932 20.106
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock S - Sale D 135,4700 -1.471 -199 26.920
2021-08-06 2021-08-04 4 Sepp-Lorenzino Laura NTLA Common Stock M - Exercise D 13,4000 26.000 348 28.391
2021-08-06 2021-08-05 4 Goddard Glenn NTLA Stock Option (right to buy) M - Exercise D 19,27 -20.000 70.000
2021-08-06 2021-08-05 4 Goddard Glenn NTLA Common Stock S - Sale D 152,1300 -530 -81 0
2021-08-06 2021-08-05 4 Goddard Glenn NTLA Common Stock S - Sale D 151,4100 -9.568 -1.449 530
2021-08-06 2021-08-05 4 Goddard Glenn NTLA Common Stock S - Sale D 150,6500 -9.902 -1.492 10.098
2021-08-06 2021-08-05 4 Goddard Glenn NTLA Common Stock M - Exercise D 19,2700 20.000 385 20.000
2021-07-06 2021-07-01 4 BASTA JAMES NTLA Stock Option (Right to Buy) A - Award D 171,65 130.000 130.000
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 143,4500 -6.149 -882 10.000
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 142,8800 -13.556 -1.937 16.149
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 141,6600 -8.420 -1.193 29.705
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 140,8000 -8.027 -1.130 38.125
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 139,9600 -52.320 -7.323 46.152
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 138,5800 -4.201 -582 98.472
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 138,0500 -5.400 -745 102.673
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 137,0100 -3.033 -416 108.073
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 135,8300 -21.893 -2.974 111.106
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 134,8600 -30.831 -4.158 132.999
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 133,7700 -36.519 -4.885 163.830
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 132,7700 -56.188 -7.460 200.349
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 131,8200 -53.823 -7.095 256.537
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 130,7900 -66.468 -8.693 310.360
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 129,8800 -48.724 -6.328 376.828
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 128,7700 -56.280 -7.247 425.552
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 127,7900 -55.525 -7.096 481.832
2021-06-29 2021-06-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 127,0200 -26.019 -3.305 537.357
2021-06-25 2021-06-23 4 Verwiel Frank NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 Verwiel Frank NTLA Common Stock A - Award D 2.094 2.094
2021-06-25 2021-06-23 4 Keresty Georgia NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 Keresty Georgia NTLA Common Stock A - Award D 2.094 2.094
2021-06-25 2021-06-23 4 GOODMAN JESSE NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 GOODMAN JESSE NTLA Common Stock A - Award D 2.094 2.094
2021-06-25 2021-06-23 4 FORMELA JEAN FRANCOIS NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 FORMELA JEAN FRANCOIS NTLA Common Stock A - Award D 2.094 2.094
2021-06-25 2021-06-23 4 DORSA CAROLINE NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 DORSA CAROLINE NTLA Common Stock A - Award D 2.094 2.094
2021-06-25 2021-06-23 4 Crowley John F NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 Crowley John F NTLA Common Stock A - Award D 2.094 2.094
2021-06-25 2021-06-23 4 Cohen Fred E NTLA Stock Option (right to buy) A - Award D 83,59 3.382 3.382
2021-06-25 2021-06-23 4 Cohen Fred E NTLA Common Stock A - Award D 2.094 2.094
2021-06-15 2021-06-14 4 FORMELA JEAN FRANCOIS 1See Footnote NTLA Common Stock S - Sale I 89,2500 -653 -58 563.376
2021-06-15 2021-06-14 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 88,7000 -13.309 -1.181 564.029
2021-06-15 2021-06-14 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 87,7500 -93.102 -8.170 577.338
2021-06-15 2021-06-14 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 86,7300 -47.422 -4.113 670.440
2021-06-15 2021-06-14 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 85,9200 -16.293 -1.400 717.862
2021-06-15 2021-06-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 85,9800 -1.875 -161 734.155
2021-06-15 2021-06-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 85,1800 -29.071 -2.476 736.030
2021-04-30 2021-04-29 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 85,4300 -4.513 -386 765.101
2021-04-28 2021-04-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 86,1200 -29.740 -2.561 769.614
2021-04-28 2021-04-28 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 85,4000 -102.186 -8.727 799.354
2021-04-28 2021-04-27 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 87,0800 -61.680 -5.371 901.540
2021-04-28 2021-04-27 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 86,4100 -68.836 -5.948 963.220
2021-04-28 2021-04-27 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 85,3900 -79.714 -6.807 1.032.056
2021-04-28 2021-04-26 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 84,9300 -806 -68 1.111.770
2021-04-15 2021-04-13 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,88 -15.937 15.937
2021-04-15 2021-04-13 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 10.000
2021-04-15 2021-04-13 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,8800 15.937 221 719.305
2021-04-15 2021-04-13 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 10.000 68 703.368
2021-04-13 2021-04-09 4 Keresty Georgia NTLA Stock Option (right to buy) A - Award D 70,64 7.755 7.755
2021-04-13 2021-04-09 4 Keresty Georgia NTLA Common Stock A - Award D 4.955 4.955
2021-04-07 2021-04-05 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 84,9800 -800 -68 1.112.576
2021-04-06 2021-04-05 4 DORSA CAROLINE NTLA Stock Option (right to buy) M - Exercise D 6,40 -7.500 9.088
2021-04-06 2021-04-05 4 DORSA CAROLINE NTLA Common Stock S - Sale D 82,9900 -800 -66 5.410
2021-04-06 2021-04-05 4 DORSA CAROLINE NTLA Common Stock S - Sale D 82,3500 -4.686 -386 6.210
2021-04-06 2021-04-05 4 DORSA CAROLINE NTLA Common Stock S - Sale D 81,4900 -2.014 -164 10.896
2021-04-06 2021-04-05 4 DORSA CAROLINE NTLA Common Stock M - Exercise D 6,4000 7.500 48 12.910
2021-04-02 2021-04-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,40 -26.041 273.959
2021-04-02 2021-04-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 14,58 -45.000 155.000
2021-04-02 2021-04-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 83,0000 -13.895 -1.153 693.368
2021-04-02 2021-04-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,4000 26.041 349 707.263
2021-04-02 2021-04-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 84,0000 -24.314 -2.042 681.222
2021-04-02 2021-04-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 14,5800 45.000 656 705.536
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -33.001 6.116
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 14,58 -10.000 51.000
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 18,30 -21.000 29.090
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 13,88 -33.000 39.000
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 85,7600 -124 -11 162.388
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 84,7300 -1.213 -103 162.512
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 83,8500 -2.258 -189 163.725
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 82,7700 -3.361 -278 165.983
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 81,8700 -6.768 -554 169.344
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 80,8500 -1.965 -159 176.112
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 33.001 225 178.077
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 85,1400 -123 -10 145.076
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 83,9800 -1.049 -88 145.199
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 82,8700 -951 -79 146.248
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 81,9500 -2.644 -217 147.199
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 80,7300 -700 -57 149.843
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 14,5800 10.000 146 150.543
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 84,8700 -963 -82 140.543
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 83,7200 -1.724 -144 141.506
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 82,6300 -2.728 -225 143.230
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 81,8300 -4.818 -394 145.958
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 80,8200 -1.256 -102 150.776
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 18,3000 21.000 384 152.032
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 84,9400 -1.067 -91 131.032
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 83,9100 -3.234 -271 132.099
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 82,7600 -3.233 -268 135.333
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 81,8900 -8.266 -677 138.566
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock S - Sale D 80,7900 -2.010 -162 146.832
2021-04-02 2021-04-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 13,8800 33.000 458 148.842
2021-03-05 2021-03-03 4 Sepp-Lorenzino Laura NTLA Restricted Stock Unit A - Award D 14.000 14.000
2021-03-05 2021-03-03 4 Sepp-Lorenzino Laura NTLA Stock Option (right to buy) A - Award D 57,71 84.000 84.000
2021-03-05 2021-03-03 4 SCHIERMEIER ANDREW NTLA Restricted Stock Unit A - Award D 13.125 13.125
2021-03-05 2021-03-03 4 SCHIERMEIER ANDREW NTLA Stock Option (right to buy) A - Award D 57,71 78.750 78.750
2021-03-05 2021-03-03 4 Rivera Jose E NTLA Restricted Stock Unit A - Award D 12.250 12.250
2021-03-05 2021-03-03 4 Rivera Jose E NTLA Stock Option (right to buy) A - Award D 57,71 73.500 73.500
2021-03-05 2021-03-03 4 LEONARD JOHN M. NTLA Restricted Stock Unit A - Award D 31.394 31.394
2021-03-05 2021-03-03 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 57,71 188.363 188.363
2021-03-05 2021-03-03 4 Lebwohl David NTLA Restricted Stock Unit A - Award D 12.750 12.750
2021-03-05 2021-03-03 4 Lebwohl David NTLA Stock Option (right to buy) A - Award D 57,71 76.500 76.500
2021-03-05 2021-03-03 4 Goddard Glenn NTLA Restricted Stock Unit A - Award D 12.250 12.250
2021-03-05 2021-03-03 4 Goddard Glenn NTLA Stock Option (right to buy) A - Award D 57,71 73.500 73.500
2021-03-01 2021-02-26 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 60,2909 -501.945 -30.263 1.113.376
2021-02-09 2021-02-09 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 18,30 -21.000 50.090
2021-02-09 2021-02-09 4 Rivera Jose E NTLA Common Stock S - Sale D 75,0000 -11.489 -862 117.920
2021-02-09 2021-02-09 4 Rivera Jose E NTLA Common Stock M - Exercise D 18,2950 21.000 384 129.409
2021-02-09 2021-02-09 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -56.718 68.516
2021-02-09 2021-02-09 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 75,0000 -28.043 -2.103 660.536
2021-02-09 2021-02-09 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 56.718 387 688.579
2021-02-09 2021-02-05 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,40 -40.000 285.453
2021-02-09 2021-02-05 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 68,7800 -881 -61 631.861
2021-02-09 2021-02-05 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 67,8600 -14.018 -951 632.742
2021-02-09 2021-02-05 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 67,1800 -8.043 -540 646.760
2021-02-09 2021-02-05 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,4000 40.000 536 654.803
2021-02-03 2021-02-03 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,88 -67.060 17.940
2021-02-03 2021-02-03 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 22,78 -50.000 110.000
2021-02-03 2021-02-03 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 73,0000 -36.858 -2.691 614.803
2021-02-03 2021-02-03 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,8800 67.060 931 651.661
2021-02-03 2021-02-03 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 72,0000 -30.998 -2.232 584.601
2021-02-03 2021-02-03 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 22,7800 50.000 1.139 615.599
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 22,78 -60.000 160.000
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 18,30 -30.000 27.500
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 13,88 -10.000 85.000
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -100.000 125.234
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 65,0400 -5.475 -356 565.599
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 64,1000 -16.640 -1.067 571.074
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 63,3000 -11.100 -703 587.714
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 22,7800 60.000 1.367 598.814
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 65,0300 -3.260 -212 538.814
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 64,0900 -9.432 -604 542.074
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 63,2900 -6.448 -408 551.506
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 18,3000 30.000 549 557.954
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 65,0200 -693 -45 527.954
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 64,1600 -3.497 -224 528.647
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 63,2400 -1.709 -108 532.144
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 13,8800 10.000 139 533.853
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 65,0000 -8.827 -574 523.853
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 64,1300 -26.058 -1.671 532.680
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 63,3200 -16.750 -1.061 558.738
2021-02-03 2021-02-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 100.000 683 575.488
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 14,58 -10.000 61.000
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 13,88 -33.000 72.000
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -66.000 39.117
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 65,0700 -755 -49 108.409
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 64,1800 -2.386 -153 109.164
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 63,4400 -2.326 -148 111.550
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 14,5800 10.000 146 113.876
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 65,0500 -2.827 -184 103.876
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 64,1600 -8.366 -537 106.703
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 63,3400 -6.617 -419 115.069
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 13,8800 33.000 458 121.686
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 65,0100 -5.312 -345 88.686
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 64,1100 -15.594 -1.000 93.998
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock S - Sale D 63,3100 -10.476 -663 109.592
2021-02-03 2021-02-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 66.000 451 120.068
2021-01-22 2021-01-20 4 Cohen Fred E NTLA Stock Option (right to buy) M - Exercise D 13,78 -20.000 18.000
2021-01-22 2021-01-20 4 Cohen Fred E NTLA Common Stock M - Exercise D 13,7800 20.000 276 30.000
2021-01-05 2021-01-05 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 55,8600 -6.239 -349 475.488
2021-01-05 2020-12-31 4 LEONARD JOHN M. NTLA Restricted Stock Unit (performance-based) M - Exercise D -14.375 0
2021-01-05 2020-12-31 4 LEONARD JOHN M. NTLA Restricted Stock Unit (performance-based) A - Award D 14.375 14.375
2021-01-05 2020-12-31 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 23,46 28.750 28.750
2021-01-05 2020-12-31 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 14.375 481.727
2021-01-05 2021-01-05 4 SCHIERMEIER ANDREW NTLA Common Stock S - Sale D 55,8600 -1.377 -77 16.656
2021-01-05 2020-12-31 4 SCHIERMEIER ANDREW NTLA Restricted Stock Unit (performance-based) M - Exercise D -4.792 0
2021-01-05 2020-12-31 4 SCHIERMEIER ANDREW NTLA Restricted Stock Unit (performance-based) A - Award D 4.792 4.792
2021-01-05 2020-12-31 4 SCHIERMEIER ANDREW NTLA Stock Option (right to buy) A - Award D 20,56 9.583 9.583
2021-01-05 2020-12-31 4 SCHIERMEIER ANDREW NTLA Common Stock M - Exercise D 4.792 18.033
2021-01-05 2021-01-05 4 Rivera Jose E NTLA Common Stock S - Sale D 55,8600 -2.078 -116 51.990
2021-01-05 2020-12-31 4 Rivera Jose E NTLA Restricted Stock Unit (performance-based) M - Exercise D -4.792 0
2021-01-05 2020-12-31 4 Rivera Jose E NTLA Restricted Stock Unit (performance-based) A - Award D 4.792 4.792
2021-01-05 2020-12-31 4 Rivera Jose E NTLA Stock Option (right to buy) A - Award D 23,46 9.583 9.583
2021-01-05 2020-12-31 4 Rivera Jose E NTLA Common Stock M - Exercise D 4.792 54.068
2021-01-04 2020-12-30 4 SCHIERMEIER ANDREW NTLA Stock Option (right to buy) M - Exercise D 13,48 -1.500 148.500
2021-01-04 2020-12-30 4 SCHIERMEIER ANDREW NTLA Common Stock M - Exercise D 13,4800 1.500 20 12.673
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Stock Option (right to buy) M - Exercise D 15,78 -19.000 0
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Stock Option (right to buy) M - Exercise D 14,35 -19.000 0
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Stock Option (right to buy) M - Exercise D 25,98 -19.000 0
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Stock Option (right to buy) M - Exercise D 18,00 -31.764 0
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock S - Sale D 54,3300 -21.336 -1.159 5.000
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock S - Sale D 53,6900 -45.450 -2.440 26.336
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock S - Sale D 52,5200 -21.978 -1.154 71.786
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock M - Exercise D 15,7800 19.000 300 93.764
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock M - Exercise D 25,9800 19.000 494 74.764
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock M - Exercise D 14,3500 19.000 273 55.764
2020-12-18 2020-12-17 4 KARSEN PERRY A NTLA Common Stock M - Exercise D 18,0000 31.764 572 36.764
2020-12-03 2020-12-01 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 13,88 -5.000 105.000
2020-12-03 2020-12-01 4 Rivera Jose E NTLA Common Stock S - Sale D 39,4600 -257 -10 48.708
2020-12-03 2020-12-01 4 Rivera Jose E NTLA Common Stock S - Sale D 38,4900 -1.522 -59 48.965
2020-12-03 2020-12-01 4 Rivera Jose E NTLA Common Stock S - Sale D 37,7300 -1.585 -60 50.487
2020-12-03 2020-12-01 4 Rivera Jose E NTLA Common Stock M - Exercise D 13,8800 5.000 69 52.072
2020-11-27 2020-11-27 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 14,58 -20.000 200.000
2020-11-27 2020-11-27 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 18,30 -15.000 57.500
2020-11-27 2020-11-27 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 39,0000 -20.000 -780 467.352
2020-11-27 2020-11-27 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 14,5800 20.000 292 487.352
2020-11-27 2020-11-27 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 38,0000 -15.000 -570 467.352
2020-11-27 2020-11-27 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 18,3000 15.000 274 482.352
2020-11-25 2020-11-25 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -50.000 225.234
2020-11-25 2020-11-25 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 36,0000 -50.000 -1.800 467.352
2020-11-25 2020-11-25 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 50.000 342 517.352
2020-11-18 2020-11-16 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 14,58 -20.000 220.000
2020-11-18 2020-11-16 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 34,0000 -20.000 -680 467.352
2020-11-18 2020-11-16 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 14,5800 20.000 292 487.352
2020-11-18 2020-11-18 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 18,30 -848 71.090
2020-11-18 2020-11-18 4 Rivera Jose E NTLA Common Stock S - Sale D 35,0000 -624 -22 47.072
2020-11-18 2020-11-18 4 Rivera Jose E NTLA Common Stock M - Exercise D 18,3000 848 16 47.696
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 18,30 -562 71.938
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 105.117
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Common Stock S - Sale D 35,0000 -414 -14 46.848
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Common Stock M - Exercise D 18,3000 562 10 47.262
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Common Stock S - Sale D 34,5100 -3.595 -124 46.700
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Common Stock S - Sale D 33,7500 -2.020 -68 50.295
2020-11-18 2020-11-16 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 52.315
2020-11-06 2020-11-04 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -50.000 275.234
2020-11-06 2020-11-04 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 26,0000 -50.000 -1.300 467.352
2020-11-06 2020-11-04 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 50.000 342 517.352
2020-11-06 2020-11-04 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 13,88 -5.000 110.000
2020-11-06 2020-11-04 4 Rivera Jose E NTLA Common Stock S - Sale D 28,0000 -3.364 -94 42.315
2020-11-06 2020-11-04 4 Rivera Jose E NTLA Common Stock M - Exercise D 13,8800 5.000 69 45.679
2020-10-16 2020-10-15 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 115.117
2020-10-16 2020-10-15 4 Rivera Jose E NTLA Common Stock S - Sale D 24,5500 -156 -4 40.679
2020-10-16 2020-10-15 4 Rivera Jose E NTLA Common Stock S - Sale D 24,1900 -5.459 -132 40.835
2020-10-16 2020-10-15 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 46.294
2020-10-09 2020-10-07 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -5.000 325.234
2020-10-09 2020-10-07 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 21,8300 -5.000 -109 467.352
2020-10-09 2020-10-07 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 5.000 34 472.352
2020-10-05 2020-10-02 4 Crowley John F NTLA Stock Option (Right to Buy) A - Award D 18,83 38.000 38.000
2020-09-17 2020-09-15 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 125.117
2020-09-17 2020-09-15 4 Rivera Jose E NTLA Common Stock S - Sale D 21,0400 -5.615 -118 36.294
2020-09-17 2020-09-15 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 41.909
2020-09-03 2020-09-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -5.000 330.234
2020-09-03 2020-09-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 21,8300 -5.000 -109 467.352
2020-09-03 2020-09-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 5.000 34 472.352
2020-08-20 2020-08-18 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 135.117
2020-08-20 2020-08-18 4 Rivera Jose E NTLA Common Stock S - Sale D 21,0000 -5.615 -118 31.909
2020-08-20 2020-08-18 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 37.524
2020-08-07 2020-08-06 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -5.000 335.234
2020-08-07 2020-08-06 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 21,8300 -5.000 -109 467.352
2020-08-07 2020-08-06 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 5.000 34 472.352
2020-07-17 2020-07-15 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 145.117
2020-07-17 2020-07-15 4 Rivera Jose E NTLA Common Stock S - Sale D 22,7000 -5.615 -127 27.524
2020-07-17 2020-07-15 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 33.139
2020-07-02 2020-07-01 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -5.000 340.234
2020-07-02 2020-07-01 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 21,8300 -5.000 -109 467.352
2020-07-02 2020-07-01 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 5.000 34 472.352
2020-06-19 2020-06-18 4 Cohen Fred E NTLA Stock Option (right to buy) A - Award D 20,72 19.000 19.000
2020-06-19 2020-06-18 4 DORSA CAROLINE NTLA Stock Option (right to buy) A - Award D 20,72 19.000 19.000
2020-06-19 2020-06-18 4 FORMELA JEAN FRANCOIS NTLA Stock Option (right to buy) A - Award D 20,72 19.000 19.000
2020-06-19 2020-06-18 4 GOODMAN JESSE NTLA Stock Option (right to buy) A - Award D 20,72 19.000 19.000
2020-06-19 2020-06-18 4 KARSEN PERRY A NTLA Stock Option (right to buy) A - Award D 20,72 19.000 19.000
2020-06-19 2020-06-18 4 Verwiel Frank NTLA Stock Option (right to buy) A - Award D 20,72 19.000 19.000
2020-06-18 2020-06-16 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 155.117
2020-06-18 2020-06-16 4 Rivera Jose E NTLA Common Stock S - Sale D 21,0000 -5.615 -118 22.282
2020-06-18 2020-06-16 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 27.897
2020-06-05 2020-06-03 4 LEONARD JOHN M. NTLA Stock Option (right to buy) M - Exercise D 6,83 -5.000 345.234
2020-06-05 2020-06-03 4 LEONARD JOHN M. NTLA Common Stock S - Sale D 21,8300 -5.000 -109 467.352
2020-06-05 2020-06-03 4 LEONARD JOHN M. NTLA Common Stock M - Exercise D 6,8300 5.000 34 472.352
2020-05-28 2020-05-26 4 Rivera Jose E NTLA Stock Option (right to buy) M - Exercise D 6,83 -10.000 165.117
2020-05-28 2020-05-26 4 Rivera Jose E NTLA Common Stock S - Sale D 21,2100 -5.615 -119 280.107
2020-05-28 2020-05-26 4 Rivera Jose E NTLA Common Stock M - Exercise D 6,8300 10.000 68 285.722
2020-05-05 2020-05-01 4 Lebwohl David NTLA Stock Option (Right to Buy) A - Award D 12,62 200.000 200.000
2020-03-04 2020-03-02 4 Sepp-Lorenzino Laura NTLA Stock Option (Right to Buy) A - Award D 13,40 135.000 135.000
2020-03-04 2020-03-02 4 LEONARD JOHN M. NTLA Stock Option (Right to Buy) A - Award D 13,40 340.000 340.000
2020-03-04 2020-03-02 4 SCHIERMEIER ANDREW NTLA Stock Option (Right to Buy) A - Award D 13,40 135.000 135.000
2020-03-04 2020-01-03 4 SCHIERMEIER ANDREW NTLA Stock Option (Right to Buy) A - Award D 13,48 15.000 15.000
2020-03-04 2020-03-02 4 Goddard Glenn NTLA Stock Option (Right to Buy) A - Award D 13,40 125.000 125.000
2020-03-04 2020-03-02 4 Rivera Jose E NTLA Stock Option (Right to Buy) A - Award D 13,40 125.000 125.000
2019-08-02 2019-08-01 4 SCHIERMEIER ANDREW NTLA Stock Option (Right to Buy) A - Award D 18,09 55.000 55.000
2019-06-04 2019-06-03 4 Sepp-Lorenzino Laura NTLA Stock Option (Right to Buy) A - Award D 14,25 150.000 150.000
2019-05-22 2019-05-21 4 Cohen Fred E NTLA Stock Option (right to buy) A - Award D 15,78 19.000 19.000
2019-05-22 2019-05-21 4 DORSA CAROLINE NTLA Stock Option (right to buy) A - Award D 15,78 19.000 19.000
2019-05-22 2019-05-21 4 FORMELA JEAN FRANCOIS NTLA Stock Option (right to buy) A - Award D 15,78 19.000 19.000
2019-05-22 2019-05-21 4 GOODMAN JESSE NTLA Stock option (right to buy) A - Award D 15,78 19.000 19.000
2019-05-22 2019-05-21 4 KARSEN PERRY A NTLA Stock Option (right to buy) A - Award D 15,78 19.000 19.000
2019-05-22 2019-05-21 4 Verwiel Frank NTLA Stock Option (right to buy) A - Award D 15,78 19.000 19.000
2019-03-12 2019-03-06 4 SCHIERMEIER ANDREW NTLA Common Stock P - Purchase D 15,5000 4.250 66 7.500
2019-03-12 2019-03-06 4 SCHIERMEIER ANDREW NTLA Common Stock P - Purchase D 16,0000 3.250 52 3.250
2019-03-05 2019-03-01 4 Cohen Fred E NTLA Common Stock A - Award D 16,8936 10.000 169 10.000
2019-02-14 2018-07-16 5 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock J - Other D 25.074 4.352.295
2019-02-14 2018-06-18 5 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock J - Other D 25.074 4.327.221
2019-02-14 2018-05-16 5 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock J - Other D 25.074 4.302.147
2019-01-24 2019-01-23 4 Cohen Fred E NTLA Stock Option (Right to Buy) A - Award D 13,78 38.000 38.000
2018-12-20 2018-11-01 4/A Goddard Glenn NTLA Stock Option (Right to Buy) A - Award D 19,27 90.000 90.000
2018-12-20 2018-12-18 4 Goddard Glenn NTLA Stock Option (right to buy) A - Award D 14,58 17.750 17.750
2018-12-20 2018-12-18 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 14,58 240.000 240.000
2018-12-20 2018-12-18 4 SCHIERMEIER ANDREW NTLA Stock Option (right to buy) A - Award D 14,58 81.000 81.000
2018-12-20 2018-12-18 4 Rivera Jose E NTLA Stock Option (right to buy) A - Award D 14,58 71.000 71.000
2018-11-01 2018-11-01 4 Goddard Glenn NTLA Stock Option (Right to Buy) A - Award D 19,27 90.000 90.000
2018-10-31 2018-10-29 4 GOODMAN JESSE NTLA Stock Option (Right to Buy) A - Award D 18,52 38.000 38.000
2018-07-18 2018-07-16 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 31,9275 -1.402 -45 0
2018-07-18 2018-07-16 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 30,9680 -5.284 -164 1.402
2018-06-20 2018-06-19 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 28,3900 -1.400 -40 0
2018-06-20 2018-06-19 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 27,8400 -5.286 -147 1.400
2018-05-21 2018-05-17 4 Verwiel Frank NTLA Stock Option (right to buy) A - Award D 25,98 19.000 19.000
2018-05-21 2018-05-17 4 DORSA CAROLINE NTLA Stock Option (right to buy) A - Award D 25,98 19.000 19.000
2018-05-21 2018-05-17 4 KARSEN PERRY A NTLA Stock Option (right to buy) A - Award D 25,98 19.000 19.000
2018-05-21 2018-05-17 4 FORMELA JEAN FRANCOIS NTLA Stock Option (right to buy) A - Award D 25,98 19.000 19.000
2018-05-17 2018-05-16 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 25,0358 -6.686 -167 0
2018-05-15 2018-05-14 4 LEONARD JOHN M. By Trust NTLA Common Stock S - Sale I 24,0000 -8.400 -202 0
2018-05-02 2018-05-01 4 SCHIERMEIER ANDREW NTLA Stock Option (right to buy) A - Award D 20,56 23.500 23.500
2018-03-30 2018-03-28 4 Bell Graeme NTLA Stock Option (Right to buy) M - Exercise D 13,48 -8.000 202.000
2018-03-30 2018-03-28 4 Bell Graeme NTLA Common Stock M - Exercise D 13,4800 8.000 108 21.400
2018-03-26 2018-03-23 4 DORSA CAROLINE NTLA Common Stock A - Award D 24,0500 410 10 5.410
2018-03-23 3 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock D 8.554.146
2018-03-23 3 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock D 8.554.146
2018-03-23 3 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock D 8.554.146
2018-03-23 3 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock D 8.554.146
2018-03-22 2018-03-20 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 23,7840 -36.628 -871 0
2018-03-22 2018-03-20 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 25,0601 -2.617 -66 36.628
2018-01-30 2018-01-29 4 Caribou Biosciences, Inc. NTLA Common Stock S - Sale I 26,7800 -550.645 -14.746 3.994.355
2018-01-29 2018-01-25 4 Rivera Jose E NTLA Stock Option (right to buy) A - Award D 22,78 25.000 25.000
2018-01-29 2018-01-25 4 Bell Graeme NTLA Stock Option (right to buy) A - Award D 22,78 25.000 25.000
2018-01-29 2018-01-25 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 22,78 220.000 220.000
2017-12-14 2017-12-12 4 Bell Graeme NTLA Stock Option (right to buy) A - Award D 18,30 72.500 72.500
2017-12-14 2017-12-12 4 Bermingham Nessan NTLA Stock Option (right to buy) A - Award D 18,30 292.500 292.500
2017-12-14 2017-12-12 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 18,30 72.500 72.500
2017-12-14 2017-12-12 4 Rivera Jose E NTLA Stock Option (right to buy) A - Award D 18,30 72.500 72.500
2017-12-14 2017-12-12 4 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock S - Sale D 18,3000 -1.523.000 -27.871 4.129.903
2017-12-08 2017-12-08 4 Bermingham Nessan NTLA Common Stock S - Sale D 20,8210 -94.143 -1.960 458.250
2017-12-08 2017-12-07 4 Bermingham Nessan NTLA Common Stock S - Sale D 21,4572 -27.566 -591 552.393
2017-12-08 2017-12-07 4 Bermingham Nessan NTLA Common Stock S - Sale D 21,0514 -103.574 -2.180 579.959
2017-12-08 2017-12-06 4 Bermingham Nessan NTLA Common Stock S - Sale D 20,8398 -12.467 -260 683.533
2017-12-08 2017-12-06 4 Bermingham Nessan NTLA Common Stock S - Sale D 20,2780 -99.033 -2.008 696.000
2017-11-03 2017-11-03 4 Bell Graeme NTLA Common Stock A - Award D 22,0433 5.000 110 13.400
2017-09-13 2017-09-13 4 Caribou Biosciences, Inc. NTLA Common Stock S - Sale I -1.048.846 4.545.000
2017-07-25 2017-07-25 4 Verwiel Frank NTLA Stock Option (right to buy) A - Award D 16,91 38.000 38.000
2017-07-25 2017-07-25 4 Slaoui Moncef NTLA Stock Option (right to buy) A - Award D 16,91 38.000 38.000
2017-07-11 2017-07-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 16,0695 -80.000 -1.286 3.579.788
2017-07-11 2017-07-10 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 16,1722 -40.000 -647 3.659.788
2017-07-11 2017-07-07 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 16,7664 -30.000 -503 3.699.788
2017-07-11 2017-07-11 4 Atlas Venture Fund IX, L.P. NTLA Common Stock S - Sale D 16,0695 -80.000 -1.286 3.579.788
2017-07-11 2017-07-10 4 Atlas Venture Fund IX, L.P. NTLA Common Stock S - Sale D 16,1722 -40.000 -647 3.659.788
2017-07-11 2017-07-07 4 Atlas Venture Fund IX, L.P. NTLA Common Stock S - Sale D 16,7664 -30.000 -503 3.699.788
2017-06-05 2017-06-01 4 KARSEN PERRY A NTLA Common Stock A - Award D 11,9850 5.000 60 5.000
2017-06-05 2017-06-02 4 DORSA CAROLINE NTLA Common Stock A - Award D 12,4200 5.000 62 5.000
2017-06-05 2017-06-01 4 Rivera Jose E NTLA Common Stock A - Award D 12,0327 8.400 101 8.994
2017-06-05 2017-06-02 4 Bell Graeme NTLA Common Stock A - Award D 12,3736 8.400 104 8.400
2017-06-05 2017-06-01 4 Bermingham Nessan NTLA Common Stock A - Award D 11,9499 8.400 100 795.033
2017-06-05 2017-06-01 4 LEONARD JOHN M. By Trust NTLA Common Stock A - Award I 12,0900 600 7 8.400
2017-06-05 2017-06-01 4 LEONARD JOHN M. By Trust NTLA Common Stock A - Award I 12,0600 7.800 94 7.800
2017-05-19 2017-05-18 4 DORSA CAROLINE NTLA Stock Option (right to buy) A - Award D 14,35 19.000 19.000
2017-05-19 2017-05-18 4 GORDON CARL L NTLA Stock Option (right to buy) A - Award D 14,35 19.000 19.000
2017-05-19 2017-05-18 4 FORMELA JEAN FRANCOIS NTLA Stock Option (right to buy) A - Award D 14,35 19.000 19.000
2017-05-19 2017-05-18 4 KARSEN PERRY A NTLA Stock Option (right to buy) A - Award D 14,35 19.000 19.000
2017-03-13 2017-03-10 4 Atlas Venture Associates IX, L.P. NTLA Common Stock S - Sale D 14,0644 -5.504 -77 0
2017-03-13 2017-03-09 4 Atlas Venture Associates IX, L.P. NTLA Common Stock S - Sale D 13,8490 -15.628 -216 5.504
2017-03-13 2017-03-10 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 14,0644 -5.504 -77 0
2017-03-13 2017-03-09 4 FORMELA JEAN FRANCOIS NTLA Common Stock S - Sale I 13,8490 -15.628 -216 5.504
2017-03-07 2017-03-03 4 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock J - Other D 79.245 5.652.903
2017-03-07 2017-03-03 4 Atlas Venture Fund IX, L.P. NTLA Common Stock J - Other D -700.000 3.729.788
2017-01-10 2017-01-06 4 Bermingham Nessan NTLA Stock Option (right to buy) A - Award D 13,88 270.000 270.000
2017-01-10 2017-01-06 4 LEONARD JOHN M. NTLA Stock Option (right to buy) A - Award D 13,88 95.000 95.000
2017-01-10 2017-01-06 4 Barnes Thomas M. NTLA Stock Option (right to buy) A - Award D 13,88 50.500 50.500
2017-01-10 2017-01-06 4 Morrissey David V NTLA Stock Option (right to buy) A - Award D 13,88 30.000 30.000
2017-01-10 2017-01-06 4 Heifner Nicole NTLA Stock Option (right to buy) A - Award D 13,88 28.500 28.500
2017-01-10 2017-01-06 4 Rivera Jose E NTLA Stock Option (right to buy) A - Award D 13,88 115.000 115.000
2017-01-05 2017-01-03 4 Bell Graeme NTLA Stock Option (right to buy) A - Award D 13,48 210.000 210.000
2016-05-13 2016-05-11 4 Temasek Holdings (Private) Ltd Held by TLS Beta Pte. Ltd NTLA Series B Preferred Stock C - Conversion I -490.527 0
2016-05-13 2016-05-11 4 Temasek Holdings (Private) Ltd NTLA Common Stock P - Purchase I 18,0000 300.000 5.400 790.527
2016-05-13 2016-05-11 4 Temasek Holdings (Private) Ltd Held by TLS Beta Pte. Ltd. NTLA Common Stock C - Conversion I 490.527 490.527
2016-05-13 2016-05-11 4 ORBIMED ADVISORS LLC NTLA Series B Preferred Stock C - Conversion I -873.475 0
2016-05-13 2016-05-11 4 ORBIMED ADVISORS LLC NTLA Series B Preferred Stock C - Conversion I -2.857.143 0
2016-05-13 2016-05-11 4 ORBIMED ADVISORS LLC NTLA Common Stock P - Purchase I 18,0000 58.534 1.054 2.662.180
2016-05-13 2016-05-11 4 ORBIMED ADVISORS LLC NTLA Common Stock P - Purchase I 18,0000 191.466 3.446 2.603.646
2016-05-13 2016-05-11 4 ORBIMED ADVISORS LLC NTLA Common Stock C - Conversion I 564.780 2.412.180
2016-05-13 2016-05-11 4 ORBIMED ADVISORS LLC NTLA Common Stock C - Conversion I 1.847.400 1.847.400
2016-05-11 2016-05-11 4 Bermingham Nessan NTLA Founder Stock C - Conversion D -675.883 0
2016-05-11 2016-05-11 4 Bermingham Nessan NTLA Common Stock C - Conversion D 437.019 786.633
2016-05-11 2016-05-11 4 GORDON CARL L NTLA Series B Preferred Stock C - Conversion I -873.475 0
2016-05-11 2016-05-11 4 GORDON CARL L NTLA Series B Preferred Stock C - Conversion I -2.857.143 0
2016-05-11 2016-05-11 4 GORDON CARL L NTLA Common Stock P - Purchase I 18,0000 58.534 1.054 2.662.180
2016-05-11 2016-05-11 4 GORDON CARL L NTLA Common Stock P - Purchase I 18,0000 191.466 3.446 2.603.646
2016-05-11 2016-05-11 4 GORDON CARL L NTLA Common Stock C - Conversion I 564.780 2.412.180
2016-05-11 2016-05-11 4 GORDON CARL L NTLA Common Stock C - Conversion I 1.847.400 1.847.400
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Series B Preferred Stock C - Conversion I -761.905 0
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Series A-2 Preferred Stock C - Conversion I -1.333.333 0
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Series A-1 Preferred Stock C - Conversion I -3.809.524 0
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Founder Stock C - Conversion I -946.237 0
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock C - Conversion I 492.640 4.429.788
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock C - Conversion I 862.120 3.937.148
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock C - Conversion I 2.463.201 3.075.028
2016-05-11 2016-05-11 4 FORMELA JEAN FRANCOIS NTLA Common Stock C - Conversion I 611.827 611.827
2016-05-11 2016-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NTLA Series B Preferred Stock C - Conversion I 0,00 -1.232.130 0
2016-05-11 2016-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NTLA Series B Preferred Stock C - Conversion I 0,00 -101.204 0
2016-05-11 2016-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NTLA Common Stock P - Purchase I 18,0000 179.531 3.232 976.214
2016-05-11 2016-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NTLA Common Stock P - Purchase I 18,0000 20.469 368 85.906
2016-05-11 2016-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NTLA Common Stock C - Conversion I 796.683 796.683
2016-05-11 2016-05-11 4 BAKER BROS. ADVISORS LP See Footnotes NTLA Common Stock C - Conversion I 65.437 65.437
2016-05-11 2016-05-11 4 Haurwitz Rachel E. NTLA Junior Preferred Stock C - Conversion I -8.110.599 0
2016-05-11 2016-05-11 4 Haurwitz Rachel E. NTLA Founder Stock C - Conversion I -270.352 0
2016-05-11 2016-05-11 4 Haurwitz Rachel E. NTLA Common Stock C - Conversion I 5.244.234 5.593.846
2016-05-11 2016-05-11 4 Haurwitz Rachel E. NTLA Common Stock C - Conversion I 174.806 349.612
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Series B Preferred Stock C - Conversion D -761.905 0
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Series A-2 Preferred Stock C - Conversion D -1.333.333 0
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Series A-1 Preferred Stock C - Conversion D -3.809.524 0
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Founder Stock C - Conversion D -946.237 0
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Common Stock C - Conversion D 492.640 4.429.788
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Common Stock C - Conversion D 862.120 3.937.148
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Common Stock C - Conversion D 2.463.201 3.075.028
2016-05-11 2016-05-11 4 Atlas Venture Fund IX, L.P. NTLA Common Stock C - Conversion D 611.827 611.827
2016-05-11 2016-05-11 4 Caribou Therapeutics Holdco, LLC NTLA Junior Preferred Stock C - Conversion D -8.110.599 0
2016-05-11 2016-05-11 4 Caribou Therapeutics Holdco, LLC NTLA Founder Stock C - Conversion D -270.352 0
2016-05-11 2016-05-11 4 Caribou Therapeutics Holdco, LLC NTLA Common Stock C - Conversion D 5.244.234 5.593.846
2016-05-11 2016-05-11 4 Caribou Therapeutics Holdco, LLC NTLA Common Stock C - Conversion D 174.806 349.612
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Series B Preferred Stock C - Conversion D -761.905 0
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Series A-2 Preferred Stock C - Conversion D -2.666.666 0
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Series A-1 Preferred Stock C - Conversion D -4.761.905 0
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock P - Purchase D 18,0000 277.777 5.000 5.573.658
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock C - Conversion D 492.640 5.295.881
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock C - Conversion D 1.724.240 4.803.241
2016-05-11 2016-05-11 4 Novartis Institutes for BioMedical Research, Inc. NTLA Common Stock C - Conversion D 3.079.001 3.079.001
2016-05-09 2016-05-05 4 DORSA CAROLINE NTLA Stock Option (right to buy) A - Award D 18,00 15.176 15.176
2016-05-09 2016-05-05 4 KARSEN PERRY A NTLA Stock Option (right to buy) A - Award D 18,00 31.764 31.764
2016-05-09 2016-05-05 4 GORDON CARL L NTLA Stock Option (right to buy) A - Award D 18,00 23.529 23.529
2016-05-09 2016-05-05 4 FORMELA JEAN FRANCOIS NTLA Stock Option (right to buy) A - Award D 18,00 23.529 23.529
2016-05-09 2016-05-05 4 Haurwitz Rachel E. NTLA Stock Option (right to buy) A - Award D 18,00 23.529 23.529
2016-05-05 3 Heifner Nicole NTLA Common Stock D 129.410
2016-05-05 3 Heifner Nicole NTLA Common Stock D 129.410
2016-05-05 3 Haurwitz Rachel E. NTLA Common Stock I 349.612
2016-05-05 3 Haurwitz Rachel E. NTLA Common Stock I 349.612
2016-05-05 3 Srivastava Sapna NTLA Common Stock D 318.062
2016-05-05 3 Srivastava Sapna NTLA Common Stock D 318.062
2016-05-05 3 Rivera Jose E NTLA Common Stock I 524.420
2016-05-05 3 Rivera Jose E NTLA Common Stock I 524.420
2016-05-05 3 Morrissey David V NTLA Common Stock D 349.614
2016-05-05 3 Morrissey David V NTLA Common Stock D 349.614
2016-05-05 3 LEONARD JOHN M. By Trust NTLA Common Stock I 582.835
2016-05-05 3 LEONARD JOHN M. By Trust NTLA Common Stock I 582.835
2016-05-05 3 LEONARD JOHN M. NTLA Common Stock D 990.425
2016-05-05 3 LEONARD JOHN M. NTLA Common Stock D 990.425
2016-05-05 3 Barnes Thomas M. NTLA Common Stock D 349.614
2016-05-05 3 Barnes Thomas M. NTLA Common Stock D 349.614
2016-05-05 3 Bermingham Nessan NTLA Common Stock D 699.228
2016-05-05 3 Bermingham Nessan NTLA Common Stock D 699.228
2016-05-05 3 Caribou Biosciences, Inc. NTLA Common Stock D 349.612
2016-05-05 3 Caribou Biosciences, Inc. NTLA Common Stock D 349.612
2016-05-05 3 Caribou Biosciences, Inc. NTLA Common Stock D 349.612
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)
Other Listings
GB:0JBU
DE:38I 9,73 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista